From: Shifted phase of EEG cross-frequency coupling in individuals with Phelan-McDermid syndrome
 | PMS (n = 26) | TD (n = 15) |
---|---|---|
Sex | 10 (M) 16 (F) | 9 (M) 6 (F) |
Collection site* | ||
 Icahn School of Medicine at Mount Sinai | 11 (42.3%) | 10 (33%) |
 Rush University Medical Center | 8 (30.8%) | 5 (67%) |
 Boston Children’s Hospital | 7 (26.9%) | 0 (0%) |
Net type | ||
 Hydrocel 128 | 18 (69%) | 10 (33%) |
 Biosemi 32 | 8 (31%) | 5 (67%) |
Age (years) | 9.5 ± 4.25 | 10.0 ± 2.39 |
ASD diagnosis | ||
 ASD | 11 (42%) | 0 (0%) |
 Non-ASD | 14 (54%) | 15 (100%) |
 Unknown | 1 (4%) | 0 (0%) |
ADOS | ||
 Completed | 22 (85%) | 0 (0%) |
 Comparison score | 6.05 (2.54) | – |
Vineland | ||
 Completed | 25 (96%) | 0 (0%) |
 Adaptive behavior composite standard score | 52.8 ± 13.4 | – |
 Communication composite standard score | 58.0 ± 14.6 | – |
SSP | ||
 Completed | 22 (85%) | 3 (20%) |
 Total score | 143.9 ± 16.5 | 178.7 ± 17.1 |
RBS-R | ||
 Completed | 23 (88%) | 0 (0%) |
 Total score | 16.26 ± 15.7 | – |
MSEL | ||
 Completed | 16 (61.5%) | 0 (0%) |
 NVIQ | 19.98 ± 10.9 | – |
SB5 | ||
 Completed | 9 (34.6%) | 0 (0%) |
 NVIQ | 46.56 ± 7.5 | – |
DAS | ||
 Completed | 2 (7.7%) | 0 (0%) |
 NVIQ | 73.50 ± .71 | – |
NVIQ | ||
 Completed | 25 (96%) | 0 (0%) |
 Non-verbal intelligence quotient | 31.4 ± 17.9 | – |
Seizure history | ||
 Yes | 4 (15.4%) | – |
 No | 21 (80.8%) | – |
 Unknown | 1 (3.8%) | 15 (100%) |
SHANK3 | – |  |
 Mutation | 7 (26.9%) | – |
 Deletion | 19 (73.1%) | – |
 Deletion size (mega base pairs) | 3.95 ± 3.0 | – |